Recorded February 9, 2022 | On-Demand Webinar
In March of 2021, Puff Bar re-entered the US vape market with its disposable e-cigarettes, claiming that since their products contain synthetic nicotine instead of tobacco-derived nicotine, they fall outside of FDA’s regulatory authority. Many other companies have followed suit, and synthetic nicotine products are rising in popularity while FDA’s Center for Tobacco Products (CTP) attempts to reign in the market for tobacco-derived nicotine products. The webinar will begin with a scientific review of synthetic nicotine, including how it is made, how testing can distinguish it from tobacco-derived nicotine, and whether it poses its own unique health concerns. Following that review, the webinar will discuss perspectives on FDA’s authority to regulate these products and consider potential regulatory approaches at the federal, state, and local levels.